Haripriya Gupta

发表

Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver

D. J. Kim, K. Suk, Haripriya Gupta, 2021, Journal of clinical medicine.

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease

K. Suk, Haripriya Gupta, E. Park, 2021, International journal of molecular sciences.

D. J. Kim, S. Baik, D. Han, 2019, Journal of clinical medicine.

Response Relating Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis

D. J. Kim, S. Baik, D. Han, 2019 .

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications

D. J. Kim, Tae-Jin Kim, K. Suk, 2021, International journal of molecular sciences.

Effect of Korean Red Ginseng on metabolic syndrome

K. Suk, Min Jea Shin, Haripriya Gupta, 2020, Journal of ginseng research.

Gut-Microbial and -Metabolomic Signatures in the Prevention of Non-Alcoholic Fatty Liver Disease by Lactobacillus Lactis and Pediococcus Pentosaceus

Do Yup Lee, D. J. Kim, K. Suk, 2020 .

Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome

Do Yup Lee, D. J. Kim, M. Kwak, 2020, Gut microbes.

Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis

H. Kwon, K. Suk, Haripriya Gupta, 2022, Microorganisms.

The Link between Gut Microbiota and Hepatic Encephalopathy

D. J. Kim, Jin-Ju Jeong, K. Suk, 2022, International journal of molecular sciences.

Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease

D. J. Kim, Jin-Ju Jeong, K. Suk, 2022, International journal of molecular sciences.

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease

Jin-Ju Jeong, K. Suk, Haripriya Gupta, 2022, Current issues in molecular biology.

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease

K. Suk, Haripriya Gupta, Raja Ganesan, 2022, Foods.

The Lactobacillus as a Probiotic: Focusing on Liver Diseases

D. J. Kim, Jin-Ju Jeong, K. Suk, 2022, Microorganisms.

New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study.

Ickwon Choi, K. Suk, Haripriya Gupta, 2022, Artificial cells, nanomedicine, and biotechnology.

Role of Gut Microbiota in Hepatocarcinogenesis

K. Suk, Min Jea Shin, Haripriya Gupta, 2019, Microorganisms.

Role of Gut Microbiota in Hepatocarcinogenesis

K. Suk, Min Jea Shin, Haripriya Gupta, 2019, Microorganisms.

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease

D. J. Kim, Jin-Ju Jeong, K. Suk, 2021, International Journal of Molecular Sciences.

Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis

D. J. Kim, K. Suk, Haripriya Gupta, 2021, Microorganisms.

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease

D. J. Kim, Jin-Ju Jeong, K. Suk, 2021, Cells.

Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment

K. Suk, Haripriya Gupta, Raja Ganesan, 2023, Journal of Microbiology.

Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease

Do Yup Lee, Je Hee Lee, Yeon Bee Kim, 2021, Clinical and translational medicine.

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Do Yup Lee, K. Suk, Min Jea Shin, 2020, Clinical and molecular hepatology.

Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease

D. J. Kim, K. Suk, Haripriya Gupta, 2020, Nutrients.

A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.

K. Suk, Haripriya Gupta, Raja Ganesan, 2023, Life sciences.

The identification of metabolites from gut microbiota in NAFLD via network pharmacology

K. Suk, Haripriya Gupta, Raja Ganesan, 2023, Scientific Reports.

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role

Jin-Ju Jeong, K. Suk, Haripriya Gupta, 2022, Biomedicines.

Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.

C. S. Bang, G. Baik, Y. Yang, 2023, Hepatology international.

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis

Do Yup Lee, K. Suk, Haripriya Gupta, 2023, Frontiers in Microbiology.

Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study

K. Suk, Haripriya Gupta, Raja Ganesan, 2022, Cells.

Diet-Regulating Microbiota and Host Immune System in Liver Disease

D. J. Kim, H. Park, Na Yeon Kim, 2021, International journal of molecular sciences.

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

K. Suk, Haripriya Gupta, Raja Ganesan, 2023, Journal of Translational Medicine.

The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis

K. Suk, Haripriya Gupta, Raja Ganesan, 2023, Artificial cells, nanomedicine, and biotechnology.

Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease

K. Suk, Haripriya Gupta, Sang Hak Han, 2023, Gut microbes.

Teaching Video NeuroImage: Slow Axial Myoclonus in Subacute Sclerosing Panencephalitis

A. Mehta, M. Javali, R. Srinivasa, 2022, Neurology.

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

K. Suk, Haripriya Gupta, Sang Hak Han, 2024, Gut microbes.

A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis.

K. Suk, Haripriya Gupta, M. Choi, 2024, Artificial cells, nanomedicine, and biotechnology.